Literature DB >> 21278249

Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease.

Eric B Dammer1, Chan Hyun Na, Ping Xu, Nicholas T Seyfried, Duc M Duong, Dongmei Cheng, Marla Gearing, Howard Rees, James J Lah, Allan I Levey, John Rush, Junmin Peng.   

Abstract

Polyubiquitin chains on substrates are assembled through any of seven lysine residues or the N terminus of ubiquitin (Ub), generating diverse linkages in the chain structure. PolyUb linkages regulate the fate of modified substrates, but their abundance and function in mammalian cells are not well studied. We present a mass spectrometry-based method to measure polyUb linkages directly from total lysate of mammalian cells. In HEK293 cells, the level of polyUb linkages was found to be 52% (Lys(48)), 38% (Lys(63)), 8% (Lys(29)), 2% (Lys(11)), and 0.5% or less for linear, Lys(6), Lys(27), and Lys(33) linkages. Tissue specificity of these linkages was examined in mice fully labeled by heavy stable isotopes (i.e. SILAC mice). Moreover, we profiled the Ub linkages in brain tissues from patients of Alzheimer disease with or without concurrent Lewy body disease as well as three cellular models of proteolytic stress: proteasome deficiency, lysosome deficiency, and heat shock. The data support that polyUb chains linked through Lys(6), Lys(11), Lys(27), Lys(29), and Lys(48) mediate proteasomal degradation, whereas Lys(63) chains are preferentially involved in the lysosomal pathway. Mixed linkages, including Lys(48), may also contribute to lysosomal targeting, as both Lys(63) and Lys(48) linkages are colocalized in LC3-labeled autophagosomes. Interestingly, heat shock treatment augments Lys(11), Lys(48), and Lys(63) but not Lys(29) linkages, and this unique pattern is similar to that in the profiled neurodegenerative cases. We conclude that different polyUb linkages play distinct roles under the three proteolytic stress conditions, and protein folding capacity in the heat shock responsive pathway might be more affected in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278249      PMCID: PMC3060499          DOI: 10.1074/jbc.M110.149633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 2.  Ubiquitylation in innate and adaptive immunity.

Authors:  Vijay G Bhoj; Zhijian J Chen
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

Review 3.  Principles of ubiquitin and SUMO modifications in DNA repair.

Authors:  Steven Bergink; Stefan Jentsch
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

Review 4.  The emerging complexity of protein ubiquitination.

Authors:  David Komander
Journal:  Biochem Soc Trans       Date:  2009-10       Impact factor: 5.407

5.  VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

Authors:  Michael A Gitcho; Jeffrey Strider; Deborah Carter; Lisa Taylor-Reinwald; Mark S Forman; Alison M Goate; Nigel J Cairns
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

6.  Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry.

Authors:  David Meierhofer; Xiaorong Wang; Lan Huang; Peter Kaiser
Journal:  J Proteome Res       Date:  2008-09-10       Impact factor: 4.466

Review 7.  A role for ubiquitin in selective autophagy.

Authors:  Vladimir Kirkin; David G McEwan; Ivana Novak; Ivan Dikic
Journal:  Mol Cell       Date:  2009-05-15       Impact factor: 17.970

8.  Prevention of amino acid conversion in SILAC experiments with embryonic stem cells.

Authors:  Sean C Bendall; Chris Hughes; Morag H Stewart; Brad Doble; Mickie Bhatia; Gilles A Lajoie
Journal:  Mol Cell Proteomics       Date:  2008-05-16       Impact factor: 5.911

9.  Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation.

Authors:  Ping Xu; Duc M Duong; Nicholas T Seyfried; Dongmei Cheng; Yang Xie; Jessica Robert; John Rush; Mark Hochstrasser; Daniel Finley; Junmin Peng
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

10.  Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration.

Authors:  Simon Paine; Lynn Bedford; Julian R Thorpe; R John Mayer; James R Cavey; Nin Bajaj; Paul W Sheppard; James Lowe; Robert Layfield
Journal:  Neurosci Lett       Date:  2009-06-07       Impact factor: 3.046

View more
  86 in total

1.  Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.

Authors:  Namrata D Udeshi; D R Mani; Thomas Eisenhaure; Philipp Mertins; Jacob D Jaffe; Karl R Clauser; Nir Hacohen; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2012-04-14       Impact factor: 5.911

Review 2.  Biologic impact of proteasome inhibition in multiple myeloma cells--from the aspects of preclinical studies.

Authors:  Teru Hideshima; Kenneth C Anderson
Journal:  Semin Hematol       Date:  2012-07       Impact factor: 3.851

3.  Comparison of native and non-native ubiquitin oligomers reveals analogous structures and reactivities.

Authors:  Grace H Pham; Ambar S J B Rana; E Nihal Korkmaz; Vivian H Trang; Qiang Cui; Eric R Strieter
Journal:  Protein Sci       Date:  2016-01-12       Impact factor: 6.725

4.  Using the ubiquitin-modified proteome to monitor protein homeostasis function.

Authors:  Andrea C Carrano; Eric J Bennett
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

5.  DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Authors:  Jia Yu; Bo Qin; Ann M Moyer; Somaira Nowsheen; Tongzheng Liu; Sisi Qin; Yongxian Zhuang; Duan Liu; Shijia W Lu; Krishna R Kalari; Daniel W Visscher; John A Copland; Sarah A McLaughlin; Alvaro Moreno-Aspitia; Donald W Northfelt; Richard J Gray; Zhenkun Lou; Vera J Suman; Richard Weinshilboum; Judy C Boughey; Matthew P Goetz; Liewei Wang
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

6.  SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.

Authors:  Yan Liu; Zhenhua Zheng; Bo Shu; Jin Meng; Yuan Zhang; Caishang Zheng; Xianliang Ke; Peng Gong; Qinxue Hu; Hanzhong Wang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  Major Histocompatibility Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination.

Authors:  Richard Golnik; Andrea Lehmann; Peter-Michael Kloetzel; Frédéric Ebstein
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

Review 8.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

9.  Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes.

Authors:  Christopher M Rose; Marta Isasa; Alban Ordureau; Miguel A Prado; Sean A Beausoleil; Mark P Jedrychowski; Daniel J Finley; J Wade Harper; Steven P Gygi
Journal:  Cell Syst       Date:  2016-09-22       Impact factor: 10.304

10.  Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.

Authors:  Sunan Li; Iqbal Ahmad; Jing Shi; Bin Wang; Changqing Yu; Lixin Zhang; Yong-Hui Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.